share_log

Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders

Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders

Cronos Group Inc.宣佈2024年股東大會結果
Cronos Group ·  06/21 12:00

TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") announces that at its Annual Meeting of Shareholders held yesterday, June 20, 2024 (the "Meeting"), shareholders holding a total of 274,097,252 common shares of the Company voted in person or by proxy, representing 71.75% of the total number of common shares of the Company outstanding.

2024年6月21日,多倫多(全球新聞線)-Cronos Group Inc.(納斯達克股票代碼:CRON,tsx代碼:cron)(以下簡稱“Cronos”或“公司”)宣佈, 在昨天2024年6月20日舉行的股東年會上,持有公司總共274,097,252股普通股的股東進行了親自出席或委託代理投票,佔公司流通普通股總數的71.75%。

Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 26, 2024 was elected as a director of the Company, with each director receiving in excess of 93.4% of the votes cast in favor of his or her election. The detailed results of the vote for the election of directors are as follows:

公司在確定的代理陳述書(於2024年4月26日確定)中列出的每位董事候選人都當選爲公司董事,每位董事獲得超過93.4%的選票贊成其當選。董事選舉的詳細結果如下:

Name of Director Number of Shares Voted For Percentage of Shares Voted For Number of Shares Withheld from Voting Percentage of Shares Withheld from Voting
Jason Adler 215,118,391 98.33% 3,654,113 1.67%
Murray Garnick 215,949,040 98.71% 2,823,464 1.29%
Michael Gorenstein 204,416,959 93.44% 14,355,545 6.56%
Kamran Khan 207,976,756 95.07% 10,795,748 4.93%
Dominik Meier 208,048,529 95.10% 10,723,975 4.90%
James Rudyk 215,011,800 98.28% 3,760,704 1.72%
Elizabeth Seegar 205,934,088 94.13% 12,838,416 5.87%
董事姓名 獲得選票股數 獲得選票股數佔總股本的百分比 棄權投票股數 棄權投票股數佔總股本的百分比
Jason Adler 215,118,391 98.33% 3,654,113 1.67%
Murray Garnick 215,949,040 98.71% 2,823,464 1.29%
Michael Gorenstein 204,416,959 93.44% 14,355,545 6.56%
Kamran Khan 207,976,756 95.07% 10,795,748 4.93%
Dominik Meier 208,048,529 95.10% 10,723,975 4.90%
James Rudyk 215,011,800 98.28% 3,760,704 1.72%
Elizabeth Seegar 205,934,088 94.13% 12,838,416 5.87%

Shareholders also approved an advisory (non-binding) resolution on the compensation of the Company's named executive officers, with 96.19% of votes cast in favor of such resolution, and approved the adjournment of the Meeting to a later date to permit the Company to complete the search for a successor independent auditor.

股東們還批准了一項關於公司命名高管的薪酬的諮詢(非約束性)決議,其中96.19%的投票贊成此決議,並批准將會議延期到稍後的日期,以便公司完成尋找繼任獨立核數師的工作。

At the time of the Meeting, the Company had not completed its process to identify, and make a recommendation with respect to the appointment by the shareholders of, a successor independent auditor. Accordingly, Proposal No. 3 regarding the appointment of an independent registered public accounting firm to serve as the Company's independent auditor for the fiscal year ending December 31, 2024 and to authorize the Board of Directors of the Company (the "Board") to fix the independent auditor's remuneration was not presented to shareholders and, with the approval of the shareholders, the Meeting was adjourned to permit the Company to complete the search for a successor auditor. At the reconvened Meeting, shareholders will be asked to vote on the appointment of the successor independent auditor and the authorization of the Board to fix the successor independent auditor's remuneration. Once a successor auditor is identified, the Company will disseminate to shareholders information regarding the identity of the proposed independent registered public accounting firm to serve as the Company's independent auditor and to audit the consolidated financial statements of the Company of and for the fiscal year ending December 31, 2024, together with information regarding the reconvened Meeting.

在會議召開時,公司尚未完成確定繼任獨立核數師的程序,並對推薦由股東任命繼任獨立核數師的提案3,以及授權公司董事會(“董事會”)確定獨立核數師的酬金等事項未向股東呈現,經股東批准,會議被延期以便公司完成尋找繼任核數師的工作。在重新召開的會議上,股東將被要求就提名繼任獨立核數師和授權董事會確定繼任獨立核數師的酬金進行投票。一旦確定繼任核數師,公司將向股東播發有關擬任獨立註冊會計師事務所的身份以及審核公司截至2024年12月31日的合併財務報表的信息,連同重新召開會議的信息。

For complete results on all matters voted on at the Meeting, please see the Report of Voting Results filed on the Company's SEDAR+ profile at www.sedarplus.com and the Company's Form 8-K filed on EDGAR at www.sec.gov/edgar.

有關股東會上全部表決事項的完整結果,請參閱在公司SEDA+檔案中提交的投票結果報告,網址爲www.sedarplus.com,以及在EDGAR上提交的公司8-K表格,網址爲www.sec.gov/edgar。

About Cronos

關於Cronos:

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Cronos是一家致力於通過推進大麻研究、技術和產品開發來建立顛覆性知識產權的創新全球大麻公司。Cronos熱衷於負責任地提高消費者體驗,並正在打造一組標誌性品牌組合。 Cronos多元化的國際品牌組合包括Spinach、PEACE NATURALS和Lord Jones。有關Cronos及其品牌的更多信息,請訪問:thecronosgroup.com。

Forward-Looking Statements

前瞻性聲明

This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about Cronos' intention to build an iconic brand portfolio and develop disruptive intellectual property, identify and recommend the appointment by the shareholders of a successor independent auditor and reconvene the Meeting. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and quarterly report on Form 10-Q for the quarter ended March 31, 2024, which have been filed on SEDAR+ and EDGAR and can be accessed at www.sedarplus.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

此新聞稿可能包含構成適用加拿大和美國證券法和法院裁決(綜合稱爲“前瞻性聲明”)的信息。所有未能明顯界定歷史性質的信息均有可能構成前瞻性聲明。在某些情況下,“前瞻性陳述”可以通過使用前瞻性術語來識別,例如“可能”、“將”、“期望”、“計劃”、“預計”、“打算”、“潛在”、“估計”、“相信”或這些術語的否定形式,或者其他旨在識別前瞻性聲明的類似表達方式。此新聞發佈所包括的前瞻性聲明之一包括關於Cronos打造標誌性品牌組合和開發具有顛覆性的知識產權、確定並推薦股東任命繼任獨立核數師以及重新召開股東大會的聲明。前瞻性聲明必然是基於估計和假設的,儘管這些估計和假設經管理層認爲是合理的,但前瞻性聲明受到與商業、經濟和競爭相關的重大風險、不確定性和其他因素的固有影響,這些因素可能導致實際結果、表現或成就與前瞻性陳述所表達的預期結果、表現或成就存在重大差異。適用於公司的一些重大風險的討論可以在公司2023年12月31日結束的年度報告10-K和2024年3月31日結束的季度報告10-Q中找到,這些報告已在SEDA+和EDGAR提交併可分別通過網址www.sedarplus.com和www.sec.gov/edgar獲得。任何前瞻性聲明都是根據本新聞稿發佈日期作出的,除依法要求外,Cronos不承擔更新或修訂任何前瞻性聲明的義務。請勿過分依賴任何前瞻性聲明。

For further information, please contact:
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com

如需更多信息,請聯繫:
Shayne Laidlaw
投資者關係
電話:(416)504-0004
媒體聯繫人:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論